Biotech
Human history has been all but defined by death and disease, plague and pandemic. Advancements in 20th century medicine changed all of that. Now advancements in 21st century medicine promise to go even further. Could we bring about an end to disease? Reverse aging? Give hearing to the deaf and sight to the blind? The answer may be yes. And soon.
More
Fiber is your body’s natural guide to weight management
Fiber is important not just for happy bowel movements, but also for your blood sugar, weight, and overall health.
Exercise may or may not help you lose weight and keep it off
There isn’t a debate on the overall health benefits of regular exercise, but scientists don’t agree on whether it actually keeps weight off.
Aging is complicated – a biologist explains why no two people or cells age the same way
While some people may be older in chronological age, their biological age might be much younger. A biologist explains why.
Natural killer cells now have a better shot at destroying cancer
A 3D-printing-based approach could make immunotherapies based on natural killer (NK) cells better equipped to destroy cancer.
Neuroscience shows that speed reading is bullshit
Speed reading programs claim to teach students how to read more quickly without reducing comprehension. Research shows that they don’t work.
Not all repellents are equal – here’s how to avoid mosquito bites this summer
Researchers studied different types of mosquito repellents and their efficacy for over a decade. Here’s what they found.
A functional cure for brittle diabetes is now available in the US
Islet transplantation, a procedure shown to functionally cure some people with hard-to-control brittle diabetes, has been approved in the US.
New AI predicts who is most at risk of pancreatic cancer
An AI that identifies patients most at risk of pancreatic cancer could lead to earlier diagnosis of the deadly disease.
Viktor Frankl: The doctor who prescribed the meaning of life to his patients
Not having a meaningful life can be dreadful, and one psychologist thought it was the root of many neuroses. His ideas became Logotherapy.
Drug to grow new teeth heads to human trials
A drug that causes animals to grow new teeth could one day allow us to regenerate teeth lost to injury, disease, or old age.
If you have a complex project, follow “Gall’s law” — or it will fail
Success can be based on the fundamental observation that working complex systems arise from working simple systems.
MIT’s vaccine-enhanced CAR-T cell therapy destroys solid tumors
Adding a cancer vaccine to CAR-T cell therapy, a revolutionary treatment for blood cancers, boosts its efficacy against solid tumors.
Quantum biology: Your nose and house plants are experts at particle physics
Quantum processes, normally associated with the very small or very cold, have been found to occur in biological systems. This was unexpected.
“Zombie” cells are the key to a tiny sea creature’s full-body regeneration
A tiny sea creature’s regenerative abilities add to the growing evidence that senescent cells aren’t always detrimental.
One shot of the klotho protein boosted memory in old monkeys
A single shot of klotho, a protein linked to longevity, improved the working memory of older rhesus macaques.
Can we train our taste buds for health?
Reformulating foods tailored to the plasticity of our taste buds could be a practical and powerful tool to promote health.
First CRISPR-like system discovered in animals
A CRISPR-like gene-editing system found in animals and other complex organisms has been used to edit human cells for the first time.
New meningitis vaccine is the first to cover new emerging strain
A new meningitis vaccine that protects against five bacterial strains outperformed an existing shot in a phase 3 trial.
Newly identified type of depression affects 27% of patients
Stanford University researchers have identified a new, hard-to-treat type of depression characterized by problems with cognition.
AI-developed drug for deadly lung disease reaches phase 2 trials
AI-driven drug development has led to the launch of phase 2 trials of a drug to treat idiopathic pulmonary fibrosis (IPF).
Subscribe to the newsletter